ARCHIVES

In Brief: Holleb Named Memorial Distinguished Alumnus; Hankey Appointed DCPC Statistics Branch Chief

This article is from The Cancer Letter archive.

Vol. 15 No. 35 | September 1, 1989

Download PDF Visit The Full Archive

Related Articles

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Advocates Oppose Proposals to Market Drugs After Phase I.

June 9, 2006

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014